Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO guideline

Journal of Urology

Volumn 190, Issue 2, 2013, Pages 441-449

  Thompson, Ian M ^a,b   Valicenti, Richard K ^a,b   Albertsen, Peter ^a,b   Davis, Brian J ^a,b   Goldenberg, S Larry ^a,b   Hahn, Carol ^a,b   Klein, Eric ^a,b   Michalski, Jeff ^a,b   Roach, Mack ^a,b   Sartor, Oliver ^a,b   Wolf, J Stuart ^a,b   Faraday, Martha M ^a,b  

^a American Urological Association   (United States)

^b American Society for Radiation Oncology   (United States)

Author keywords

postoperative period; prostatectomy; prostatic neoplasms; radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMISTRY; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RAPID TEST; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL EVALUATION; EVIDENCE BASED PRACTICE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE SEXUAL DYSFUNCTION; METASTASIS; MULTIMODALITY CANCER THERAPY; PATIENT COUNSELING; PEER REVIEW; PERINEURAL INVASION; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALVAGE THERAPY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR INVASION; URINE INCONTINENCE;

EID: 84880002053     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.05.032     Document Type: Article

References (37)

1. American Cancer Society Prostate cancer key statistics. 2009 http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key- statistics Accessed November 3, 2012
2. C.L. Amling, M.L. Blute, E.J. Bergstralh Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years J Urol 164 2000 101
3. F.K. Chun, M. Graefen, M. Zacharias Anatomic radical retropubic prostatectomy - long-term recurrence-free survival rates for localized prostate cancer World J Urol 24 2005 273
4. M. Han, A.W. Partin, C.R. Pound Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555
5. F.J. Bianco Jr, P.T. Scardino, J.A. Eastham Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta") Urology 66 2005 83
6. A.J. Stephenson, P.T. Scardino, J.A. Eastham Preoperative nomogram predicting for the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 2006 715
7. P. Swindler, J.A. Eastham, M. Ohori Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens J Urol 174 2005 903
8. P.A. Kupelian, J. Katcher, H.S. Levin Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy Int J Radiat Oncol Biol Phys 377 1997 1043
9. H.M. Lee, M.J. Solan, P. Lupinacci Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): Effect of adjuvant radiotherapy Urology 64 2004 84
10. M. Ohori, T.M. Wheeler, M.W. Kattan Prognostic significance of surgical margins in radical prostatectomy specimens J Urol 154 1995 1818
11. B.A. Lowe, S.F. Lieberman Disease recurrence and progression in unrelated pathologic stage T3 prostate cancer: selecting the patient for adjuvant therapy J Urol 158 1997 1452
12. C.R. Pound, A.W. Partin, M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591
13. I.M. Thompson Jr, C.M. Tangen, J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329
14. M. Bolla, H. van Poppel, L. Collette Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572
15. T. Wiegel, D. Bottke, U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 292
16. J.R. Bernard Jr, S.J. Buskirk, M.G. Heckman Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis Int J Radiat Oncol Biol Phys 76 2010 735
17. C. Cozzarini, F. Montorsi, C. Fiorino Need for high radiation dose (> or = 70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients Int J Radiat Oncol Biol Phys 75 2009 966
18. C.R. King, M.T. Spiotto Improved outcomes with higher doses for salvage radiotherapy after prostatectomy Int J Radiat Oncol Biol Phys 71 2008 23
19. A. Siegmann, D. Bottke, J. Faehndrich Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study Strahlenther Onkol 187 2011 467
20. N. Ohri, A. Dicker, E. Trabulsi Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modeling Eur J Cancer 48 2012 837
21. J.M. Michalski, C. Lawton, I. El Naqa Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 76 2010 361 (see http://www.rtog.org/CoreLab/ContouringAtlases/ProstatePostOp.aspx for atlas)
22. M.A. Sidhom, A.B. Kneebone, M. Lehman Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group Radiother Oncol 88 2008 10
23. K.L. Wiltshire, K.K. Brock, M.A. Haider Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy Int J Radiat Oncol Biol Phys 69 2007 1090
24. P. Poortmans, A. Bossi, K. Vandeputte Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group Radiother Oncol 84 2007 121
25. M. Bolla, H. van Poppel, B. Tombal Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomized controlled trial (EORTC trial 22911) Lancet 380 2012 2018
26. I.M. Thompson, C.M. Tangen, J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial J Urol 181 2009 956
27. P.C. Albertsen, J.A. Hanley, D.F. Penson Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation J Urol 171 2004 2221
28. G.P. Swanson, M.A. Hussey, C.M. Tangen Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794 J Clin Oncol 25 2007 2225
29. R. Shinghal, C. Yemoto, J.E. McNeal Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy Prostate-specific antigen Urology 61 2003 380
30. Z.A. Dotan, F.J. Bianco Jr, F. Rabbani Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy J Clin Oncol 23 2005 1962
31. S.A. Boorjian, R.J. Karnes, P.L. Crispen Radiation therapy after radical prostatectomy: impact on metastasis and survival J Urol 182 2009 2708
32. B.J. Trock, M. Han, S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760
33. C.R. King The timing of salvage radiotherapy after radical prostatectomy: a systematic review Int J Radiat Oncol Biol Phys 84 2012 104
34. N. Ohri, A. Dicker, E. Trabulsi Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modeling Eur J Cancer 48 2012 837
35. F. Alongi, C. Fiorino, C. Cozzarini IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy Radiother Oncol 93 2009 207
36. A. Goenka, J.M. Magsanoc, X. Pei Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy Eur Urol 60 2011 1142
37. P. Ost, N. Lumen, A.S. Goessaert High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-Year results Eur Urol 60 2011 842